½ÃÀ庸°í¼­
»óǰÄÚµå
1588576

¼¼°èÀÇ Ã¼¾× °ü¸® ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå(2024-2031³â)

Global Fluid Management Monitoring System Market - 2024-2031

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: DataM Intelligence | ÆäÀÌÁö Á¤º¸: ¿µ¹® 202 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

°³¿ä

¼¼°è ü¾× °ü¸® ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀåÀº 2023³â 19¾ï 6,000¸¸ ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. 2031³â¿¡´Â 34¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2024-2031³âÀÇ ¿¹Ãø ±â°£ µ¿¾È 6.5%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

¼ö¾× °ü¸® °úÁ¤Àº ÀÇ·á ºÐ¾ß¿¡¼­ °¡Àå º¹ÀâÇÑ ºÐ¾ß Áß ÇϳªÀ̸ç, ƯÈ÷ °¢ ȯÀÚÀÇ °³º°ÀûÀÎ ¿ä±¸¸¦ Áß½ÃÇÏ´Â ÀÔ¿ø ȯÀÚ¿¡¼­ ´õ¿í ±×·¯ÇÕ´Ï´Ù. ¸¹Àº °æ¿ì, ƯÈ÷ º´»ó¿¡ ´©¿öÀִ ȯÀÚÀÇ °æ¿ì ¼ö¾× °ü¸®ÀÇ ½Å·Ú¼ºÀÌ ¼Õ»óµÇ¾î ÀÌȯÀ²°ú »ç¸Á·üÀÌ ³ô¾ÆÁö´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. µû¶ó¼­ ¼ö¾× °ü¸®´Â ¼Õ½Ç µÈ ¼ö¾×À» Æ÷ÇÔÇÑ »ý¸®Àû ¿ä±¸¸¦ ÃæÁ·½ÃŰ´Â °ÍÀÌ ¸Å¿ì Áß¿äÇÕ´Ï´Ù.

½ÃÀå ¿ªÇÐ :

¼ºÀå ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎ

¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡

½ÅÀ庴, ½ÉºÎÀü, ´ç´¢º´°ú °°Àº ¸¸¼ºÁúȯ ȯÀÚ ¼ö°¡ Áõ°¡ÇÔ¿¡ µû¶ó ü¾× °ü¸® ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ¼¼°è ½ÃÀåÀº °ý¸ñÇÒ ¸¸ÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÁúȯÀº ÇÕº´ÁõÀ» ÇÇÇϰí ÁÁÀº °á°ú¸¦ ¾ò±â À§ÇØ ½ÅÁßÇϰí Á¤È®ÇÑ ¸ð´ÏÅ͸µÀÌ ÇÊ¿äÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ÅõÀÚ·Î ÀÎÇØ ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü´Â Àû½Ã¿¡ ´õ ³ªÀº ÃÖÁ¾ °á°ú¸¦ ¾ò±â À§ÇØ ½Ç½Ã°£À¸·Î Á¤È®ÇÑ µ¥ÀÌÅ͸¦ Á¦°øÇÏ´Â °í±Þ ½Ã½ºÅÛÀ» ±¸¸ÅÇϰí ÀÖ½À´Ï´Ù.

Àα¸ÀÇ °í·ÉÈ­¿Í ¶óÀÌÇÁ½ºÅ¸ÀÏÀÇ º¯È­·Î ÀÎÇØ Àü ¼¼°èÀûÀ¸·Î ¸¸¼º ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ü¾× °ü¸® Á¦¾î¸¦ À§ÇÑ ½Å·ÚÇÒ ¼ö ÀÖ´Â ¼Ö·ç¼Ç¿¡ ´ëÇÑ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ¸¹Àº ȯÀÚÀÇ º¹ÀâÇÑ Ä¡·á¸¦ Áö¿øÇϱâ À§ÇØ ÀÌ·¯ÇÑ ½Ã½ºÅÛÀ» Áö¿øÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¿¹¸¦ µé¾î, ¸ÞÀÌ¿ä Ŭ¸®´Ð 2023¿¡ µû¸£¸é Àü¿°º´°ú ºñ°¨¿°¼º Áúȯ »çÀÌÀÇ ÀüȯÀº °øÁß º¸°ÇÀÇ °³¼±À¸·Î 1900³â´ë ÃÊ¿¡ ½ÃÀ۵Ǿú½À´Ï´Ù. °³ÀÎÀÇ ¼ö¸íÀÌ ±æ¾îÁü¿¡ µû¶ó ¸¸¼º ÁúȯÀÇ ÀÌȯÀ²°ú ºñ¿ëÀº °è¼Ó Áõ°¡ÇÏ¿© 2030³â¿¡´Â 47 Á¶ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. °³ÀÎÀÇ ¶óÀÌÇÁ ½ºÅ¸ÀÏ, Çൿ ¹× Áö¿ª »çȸ ¿äÀÎÀº ¸¸¼º ÁúȯÀÇ ¹ßº´°ú °ü¸®¿¡ Å« ¿µÇâÀ» ¹ÌĨ´Ï´Ù.

ü¾× °ü¸® ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀÇ ³ôÀº ºñ¿ë

¼¼°è ü¾× °ü¸® ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀåÀº Ä¡¿­ÇÑ °æÀïÀ» ÇÇÇÒ ¼ö ¾øÁö¸¸, ƯÈ÷ º´¿øÀÌ ÀÚ¿ø°ú ¿¹»êÀÇ Á¦¾à¿¡ ´ëóÇÏ´Â ½ÅÈï±¹ Áö¿ª¿¡¼­ ³ôÀº ºñ¿ëÀ¸·Î ÀÎÇØ ±× ÁÖ¿ä ¿øÀÎÀº ³ôÀº ºñ¿ëÀÔ´Ï´Ù. ü¾× ¹®Á¦°¡ Àִ ȯÀÚ¸¦ È¿°úÀûÀ¸·Î °ü¸®Çϱâ À§ÇØ ÇÊ¿äÇÑ °æ¿ì¿¡µµ ÀÌ·¯ÇÑ ÀçÁ¤Àû Á¦¾àÀ¸·Î ÀÎÇØ ÀÌ·¯ÇÑ Ã·´Ü Àåºñ¸¦ ´ë±Ô¸ð·Î µµÀÔÇÒ ¼ö ¾ø½À´Ï´Ù. ¶ÇÇÑ ÀÚ¿øÀÌ ºÎÁ·ÇÑ È¯°æ¿¡¼­´Â À¯Áöº¸¼ö, ±³À°, ¼ÒÇÁÆ®¿þ¾î ¾÷±×·¹ÀÌµå µîÀÇ ºñ¿ëÀ¸·Î ÀÎÇØ ÀÌ ±â¼úÀÇ È°¿ëÀÌ Á¦Çѵǰí ÀÖ½À´Ï´Ù.

¿¹¸¦ µé¾î, HysteroLux ü¾× °ü¸® ½Ã½ºÅÛ Á¦¾î ÀåÄ¡ÀÇ °¡°ÝÀº Ÿ»ç Á¦Ç°°ú ¸¶Âù°¡Áö·Î ¾à 4,000-10,000´Þ·¯·Î, ¿¹Ãø ±â°£ µ¿¾È Àüü ½ÃÀå ¼ºÀå¿¡ °É¸²µ¹ÀÌ µÇ°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§

Á¦2Àå Á¤ÀÇ¿Í °³¿ä

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå ¿ªÇÐ

  • ¿µÇâ¿äÀÎ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • ¿µÇ⠺м®

Á¦5Àå »ê¾÷ ºÐ¼®

  • PorterÀÇ Five Forces ºÐ¼®
  • °ø±Þ¸Á ºÐ¼®
  • °¡°Ý ºÐ¼®
  • ±ÔÁ¦ ºÐ¼®
  • »óȯ ºÐ¼®
  • ƯÇ㠺м®
  • SWOT ºÐ¼®
  • DMI Àǰß

Á¦6Àå Á¦Ç° À¯Çüº°

  • ü¾× °ü¸® ¼ÒÇÁÆ®¿þ¾î
  • ü¾× °ü¸® µð¹ÙÀ̽º

Á¦7Àå ¿ëµµº°

  • ¿Ü°ú ¼ö¼ú
  • ½ÉÀåÇ÷°ü ¿Ü°ú
  • Á¤Çü¿Ü°ú
  • ³ú½Å°æ ¿Ü°ú
  • ÀÏ¹Ý ¿Ü°ú
  • ºñ´¢±â ¿Ü°ú
  • ÁßȯÀÚ Ä¡·á
  • ¼Ò¾Æ°ú
  • ½Å»ý¾Æ Äɾî
  • â»ó °ü¸®

Á¦8Àå ÃÖÁ¾»ç¿ëÀÚº°

  • º´¿ø
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • Àü¹® Ŭ¸®´Ð
  • ÀçÅà ÀÇ·á Á¦°øÀÚ

Á¦9Àå À¯Åë ä³Îº°

  • Á÷Á¢ ÆÇ¸Å
  • ÀÇ·á¿ëǰ ÆÇ¸Å¾÷ü
  • ¿Â¶óÀÎ ÆÇ¸Å

Á¦10Àå Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ³²¹Ì
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ ³²¹Ì
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦11Àå °æÀï ±¸µµ

  • °æÀï ½Ã³ª¸®¿À
  • ½ÃÀå ÇöȲ/Á¡À¯À² ºÐ¼®
  • ÀμöÇÕº´(M&A) ºÐ¼®

Á¦12Àå ±â¾÷ °³¿ä

  • Baxter International Inc.
    • ±â¾÷ °³¿ä
    • Á¦Ç° Æ÷Æ®Æú¸®¿À¿Í ¼³¸í
    • À繫 °³¿ä
    • ÁÖ¿ä ¹ßÀü
  • Fresenius Medical Care AG & Co. KGaA
  • Cardinal Health, Inc.
  • Stryker Corporation
  • B. Braun Melsungen AG
  • Medtronic plc
  • Olympus Corporation
  • Smith's Medical
  • Ecolab Inc.
  • KARL STORZ GmbH & Co. KG

Á¦13Àå ºÎ·Ï

LSH 24.11.21

Overview

The global fluid management monitoring system market reached US$ 1.96 billion in 2023 and is expected to reach US$ 3.43 billion by 2031, growing at a CAGR of 6.5% during the forecast period 2024-2031.

The process of fluid management is one of the most complicated areas in medicine, especially in an inpatient setting that emphasizes the individual needs of each patient. In many instances, especially in patients that are confined to bed, the reliability of the control of hydration is impaired, with resultant high morbidity and even mortality. Fluid management, therefore, is very important because it satisfies the physiological needs, including fluids that are lost.

Market Dynamics: Drivers & Restraints

Rise in the Prevalence of Chronic Diseases

The worldwide marketplace for fluid management monitoring systems is seeing tremendous growth owing to the rising cases of chronic diseases, such as kidney disease, heart failure, diabetes, and others. Such diseases require careful and exact monitoring in order to avoid complications and ensure positive results. With such investments, healthcare providers are purchasing high-end systems that provide accurate data in real-time for timely and better end results.

As the prevalence of chronic diseases increases on the global stage with the growing aging population and lifestyle trends, the need for dependable solutions for fluid management control is projected to increase hence making these systems supportive in dealing with the care complexity of most patients.

For instance, according to Mayo Clinic 2023, the transition between infectious and noncommunicable diseases began in the early 1900s due to improved public health. As individuals live longer, chronic disease prevalence and cost continue to rise, with the estimated cost reaching $47 trillion by 2030. Individual lifestyle, behaviors, and community factors significantly influence the development and management of chronic diseases.

High costs of Fluid Management Monitoring System systems

The global fluid management monitoring systems market is not spared from the stiff competition, mostly due to the high costs involved especially in developing regions where hospitals deal with resource and budget constraints. This financial limit prevents a large-scale implementation of these advanced equipment, even when they are needed for effective management of patients with fluid problems. Also, in low resource environments, the cost of maintenance, training, and software upgrades, etc. limits the access of this technology.

For instance, HysteroLux Fluid Management System Control Unit costs around U$ 4000-10,000 like this other company products cost varies high which hinders the overall market to grow during the forecast period.

Segment Analysis

The global fluid management monitoring system market is segmented based on product type, , application, end user, distribution channel and region.

Fluid management devices segment is expected to dominate the market share

The fluid management devices segment are expected to hold a significant portion of the market share. In healthcare environments such as the operating theatre, the emergency department, and the intensive care unit, fluid management devices play an important role in controlling and measuring patient's fluid saturation levels. They allow for the monitoring of the data in real-time thereby minimizing the chances of over hydration or dehydration of a patient.

The development of technology incorporated solid state devices to allow collection, analysis of data, and easy interaction with EHR'S (Electronic Health Records) enhancing clarity of medical decisions and increasing the recovery chances in patients. Rising occurrences of chronic illnesses, geriatric populace, and less invasive surgical procedures are stimulating the uptake of these devices, making them essential devices in the system for fluid management monitoring market.

For instance, in August 2024, Watson-Marlow Fluid Technology Solutions (WMFTS) has launched WMArchitect, a flexible, single-use solution for biopharmaceutical fluid management. The platform builds on previous products like puresu and asepticsu, aiming to streamline processes, protect products, and reduce regulatory burden.

Geographical Analysis

North America is expected to hold a significant position in the fluid management monitoring system market share

North America is expected to hold a significant position in the global Fluid Management Monitoring System market during the forecast period due to the rapid growth in the geriatric population, the rise in chronic diseases, FDA clearance, the increase in research and development, an increase in technology and many more. Higher living standards and the rise in the number of people suffering from cancer has brought about an increase in demand for fluid administration systems, disposable accessories and also for minimally invasive surgeries.

For instance, in April 2024, Baxter International has received FDA 510(k) clearance for its Novum IQ large volume infusion pump (LVP) with Dose IQ Safety Software. This addition to the Novum IQ Infusion Platform, which includes Baxter's syringe infusion pump (SYR) with Dose IQ Safety Software, allows clinicians to use a single, integrated system across various patient care settings. Baxter's commitment to innovation in infusion therapy is demonstrated by offering the Novum IQ LVP in the U.S.

Moreover, in August 2022, Zynex, a medical technology company, has started enrolling in an ongoing apheresis clinical trial using its second-generation fluid monitoring system, the CM-1600. The study uses the CM-1500 and CM-1600 devices during an apheresis procedure to refine the system's patented Relative Index.

Market Segmentation

By Product Type

  • Fluid Management Software
  • Fluid Management Devices

By Application

  • Surgical Procedures
  • Cardiovascular Surgery
  • Orthopedic Surgery
  • Neurosurgery
  • General Surgery
  • Urology Surgery
  • Critical Care
  • Pediatric Care
  • Neonatal Care
  • Wound Management

By End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Home Healthcare Providers

By Distribution Channel

  • Direct Sales
  • Medical Supply Distributors
  • Online Sales

By Region

  • North America
    • The U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa

Competitive Landscape

The major global players in the market include Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, Cardinal Health, Inc., Stryker Corporation,B. Braun Melsungen AG, Medtronic plc, Olympus Corporation, Smiths Medical, Ecolab Inc, KARL STORZ GmbH & Co. KG among others.

Key Developments

  • In July 2024, Boston Scientific Corporation is considering the sale of its fluid management business, formerly North American Medical Instruments Corp., as part of its ongoing asset review. The business, which produces products for managing fluid and measuring pressure during angiography and angioplasty procedures, is expected to include the company's facilities in Glens Falls, New York and Tullamore, Ireland.

Why Purchase the Report?

  • To visualize the global fluid management monitoring system market segmentation based on product type, application, end user, distribution channel, and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of fluid management monitoring system market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global fluid management monitoring system market report would provide approximately 70 tables, 69 figures, and 202 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End User
  • 3.4. Snippet by Distribution Channel
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rise in the Prevalence of Chronic Diseases
    • 4.1.2. Restraints
      • 4.1.2.1. High Costs of Fluid Management Monitoring System Systems
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Reimbursement Analysis
  • 5.6. Patent Analysis
  • 5.7. SWOT Analysis
  • 5.8. DMI Opinion

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. Fluid Management Software*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Fluid Management Devices

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Surgical Procedures*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Cardiovascular Surgery
  • 7.4. Orthopedic Surgery
  • 7.5. Neurosurgery
  • 7.6. General Surgery
  • 7.7. Urology Surgery
  • 7.8. Critical Care
  • 7.9. Pediatric Care
  • 7.10. Neonatal Care
  • 7.11. Wound Management

8. By End User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.1.2. Market Attractiveness Index, By End User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Ambulatory Surgical Centers
  • 8.4. Specialty Clinics
  • 8.5. Home Healthcare Providers

9. By Distribution Channel

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.1.2. Market Attractiveness Index, By Distribution Channel
  • 9.2. Direct Sales*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Medical Supply Distributors
  • 9.4. Online Sales

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
      • 10.2.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
      • 10.2.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
      • 10.2.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
      • 10.2.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.3.1. The U.S.
      • 10.2.3.2. Canada
      • 10.2.3.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
      • 10.3.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
      • 10.3.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
      • 10.3.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
      • 10.3.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.3.1. Germany
      • 10.3.3.2. UK
      • 10.3.3.3. France
      • 10.3.3.4. Italy
      • 10.3.3.5. Spain
      • 10.3.3.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
      • 10.4.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
      • 10.4.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
      • 10.4.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
      • 10.4.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.3.1. Brazil
      • 10.4.3.2. Argentina
      • 10.4.3.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
      • 10.5.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
      • 10.5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
      • 10.5.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
      • 10.5.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.3.1. China
      • 10.5.3.2. India
      • 10.5.3.3. Japan
      • 10.5.3.4. South Korea
      • 10.5.3.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
      • 10.6.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
      • 10.6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
      • 10.6.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
      • 10.6.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Baxter International Inc. *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Fresenius Medical Care AG & Co. KGaA
  • 12.3. Cardinal Health, Inc.
  • 12.4. Stryker Corporation
  • 12.5. B. Braun Melsungen AG
  • 12.6. Medtronic plc
  • 12.7. Olympus Corporation
  • 12.8. Smith's Medical
  • 12.9. Ecolab Inc.
  • 12.10. KARL STORZ GmbH & Co. KG

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦